GB2129684B - A process for the production of an inactivated adjuvated vaccine against aujeszky disease - Google Patents

A process for the production of an inactivated adjuvated vaccine against aujeszky disease

Info

Publication number
GB2129684B
GB2129684B GB8328368A GB8328368A GB2129684B GB 2129684 B GB2129684 B GB 2129684B GB 8328368 A GB8328368 A GB 8328368A GB 8328368 A GB8328368 A GB 8328368A GB 2129684 B GB2129684 B GB 2129684B
Authority
GB
United Kingdom
Prior art keywords
inactivated
production
vaccine against
against aujeszky
adjuvated vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8328368A
Other versions
GB2129684A (en
GB8328368D0 (en
Inventor
Maria Kelemen
Gabor Szabo
Ferenc Solyom
Laszlo Farkas
Andras Makar
Anna Forgacs
Tibor Perenyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHYLAXIA OLTOANYAGTERMELOE
Original Assignee
PHYLAXIA OLTOANYAGTERMELOE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHYLAXIA OLTOANYAGTERMELOE filed Critical PHYLAXIA OLTOANYAGTERMELOE
Publication of GB8328368D0 publication Critical patent/GB8328368D0/en
Publication of GB2129684A publication Critical patent/GB2129684A/en
Application granted granted Critical
Publication of GB2129684B publication Critical patent/GB2129684B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB8328368A 1982-10-27 1983-10-24 A process for the production of an inactivated adjuvated vaccine against aujeszky disease Expired GB2129684B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU823441A HU187421B (en) 1982-10-27 1982-10-27 Process for producing inactivated, adjuvated serum against aujeszky's illness

Publications (3)

Publication Number Publication Date
GB8328368D0 GB8328368D0 (en) 1983-11-23
GB2129684A GB2129684A (en) 1984-05-23
GB2129684B true GB2129684B (en) 1986-06-18

Family

ID=10964044

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8328368A Expired GB2129684B (en) 1982-10-27 1983-10-24 A process for the production of an inactivated adjuvated vaccine against aujeszky disease

Country Status (6)

Country Link
CS (1) CS253709B2 (en)
DE (1) DE3335185A1 (en)
FR (1) FR2535204B1 (en)
GB (1) GB2129684B (en)
HU (1) HU187421B (en)
YU (1) YU211883A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR216081A1 (en) * 1976-07-02 1979-11-30 Dso Pharmachim A METHOD OF PREPARING AN AVIRULENT VIROSIC MUTANT FROM AUJESZKY VIRUS

Also Published As

Publication number Publication date
CS253709B2 (en) 1987-12-17
HU187421B (en) 1986-01-28
GB2129684A (en) 1984-05-23
FR2535204A1 (en) 1984-05-04
DE3335185A1 (en) 1984-05-03
CS794483A2 (en) 1987-05-14
YU211883A (en) 1987-04-30
GB8328368D0 (en) 1983-11-23
FR2535204B1 (en) 1988-01-15

Similar Documents

Publication Publication Date Title
PT77977B (en) Process for preparing a coupled h.influenza type b vaccine
HUT35643A (en) Process for producing hexqhydro-indolo-carboxylic acids
GB2211064B (en) Method for producing roux
GB2096146B (en) Process for the production of human antibodies
HUT43104A (en) Process for producing human antibodies
DE3372183D1 (en) A process for the preparation of alpha-6-deoxytetracyclines
DE3365572D1 (en) Process for the preparation of a phenylalkylaminoethylsalicylamide
YU62688A (en) Process for obtaining cyclical peptides
PT87065A (en) PROCESS FOR THE PREPARATION OF A VACCINE AGAINST PASTEURELLOSIS
HUT47846A (en) Process for producing antimalarian pharmaceutical
ZA828622B (en) Process for producing n-phosphonomethylglycine
DE3266120D1 (en) Process for preparing amino-arylsulphonic acids
DE3063561D1 (en) Method for the production of a tube
SG45180A1 (en) A process for the manufacture of 4-acetoxy-3- hydroxy-ethyl-azetidinone
DE3264098D1 (en) Process for preparing 1-alkyl-2-chloro-5-nitro-benzene-4-sulphonic acids
GB2129684B (en) A process for the production of an inactivated adjuvated vaccine against aujeszky disease
DE3260577D1 (en) Process for preparing s-aryl-thioglycolic acids
GB2205475B (en) Method for producing roux
GB8811656D0 (en) Ultrafine tube & method for its production
EP0337572A3 (en) Process for the preparation of alkanediols
DE3160783D1 (en) A process for the preparation of alkoxyalkanoic acids
DE3661418D1 (en) Process for preparing phosphonic-acid dichlorides
EP0276766A3 (en) Process for the preparation of beta-aryl alcohols
GB8822393D0 (en) Method for production of antigenic proteinhapten conjugates & antibodies corresponding thereto
PH14990A (en) Process for producing a vaccine

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee